HCWM
ABBV icon

Harrison & Co Wealth Management’s AbbVie ABBV Stock Holding History

Harrison & Co Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.09M Sell
6,758
-131
-2% -$20.1K 1.06% 26
2022
Q3 		$925K Sell
6,889
-882
-11% -$127K 0.98% 27
2022
Q2 		$1.19M Buy
7,771
+317
+4% +$48.4K 1.13% 24
2022
Q1 		$1.21M Sell
7,454
-347
-4% -$50.4K 1.06% 24
2021
Q4 		$1.06M Buy
+7,801
New +$921K 0.89% 37

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harrison & Co Wealth Management's ABBV Position: Q4 2022 in Review

Harrison & Co Wealth Management reduced its AbbVie (ABBV) stake by 1.9% in Q4 2022, selling an estimated $20.1K and leaving 6,758 shares worth $1.09M. The position accounts for 1.06% of the portfolio, ranked #26.

Harrison & Co Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.21M in Q1 2022. 3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Harrison & Co Wealth Management held 6,758 shares of AbbVie worth $1.09M as of Q4 2022.
  • Harrison & Co Wealth Management sold 131 AbbVie shares in Q4 2022, an estimated $20.1K.
  • AbbVie made up 1.06% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #26 holding.
  • Harrison & Co Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 5 quarters since.
  • Harrison & Co Wealth Management's AbbVie position peaked at $1.21M in Q1 2022.
  • 3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.